Skip to content

Checked

Class IIDrug recallOngoing

Accucaine, Kit contains: Lidocaine HCl Injection USP recall

Recalled by Asclemed USA Inc. of Torrance, CA · FDA report 07/08/2026

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
06/08/2026
Distribution
Nationwide

Reason for recall

Lack of Assurance of Sterility

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.
Lot and code info
Lot #: AE3102, 121924X2, 022525X4, 033125X1, 030426X2, 033125X2, 041725X3, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 122225X4, 010626X3, 041326X4, Exp 11/30/2026; AE5052, 041426X2, 041726X1, 051826X2, Exp 04/30/2028.
Brand names
ACCUCAINE
Recall number
D-0658-2026
Event ID
99204
Initiated by
Voluntary: Firm initiated

Where it was distributed

USA Nationwide

  • Nationwide

Recall timeline

  1. 06/08/2026Firm started the recall
  2. 07/02/2026FDA classified it as Class II
  3. 07/08/2026Published in the FDA enforcement report

All products in this recall

2 products under event 99204

More recalls from Asclemed USA

Frequently asked questions

Why was Accucaine, Kit contains: Lidocaine HCl Injection USP recalled?
Lack of Assurance of Sterility
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
USA Nationwide
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 07/08/2026 · Do not rely on openFDA to make decisions regarding medical care